Sign in

Samuel Zentman

Director at Klotho Neurosciences
Board

About Samuel Zentman

Samuel Zentman, PhD, is a non-employee independent director of Klotho Neurosciences (KLTO), age 78 as of March 26, 2025 . He holds a PhD in Complex Analysis (Wayne State University and University of Michigan) and is designated an “audit committee financial expert” under SEC rules and Nasdaq financial sophistication standards . His background spans academia (Mathematics professor, University of Detroit), computational systems leadership at American Motors, and senior operating and financial roles as CFO and CEO of Manhattan Textile Corporation .

Past Roles

OrganizationRoleTenureCommittees/Impact
University of DetroitMathematics ProfessorNot disclosed Academic leadership
American Motors CorporationSystems Analyst; Manager, Engineering Computer Center; Director, Corporate Computer CenterNot disclosed Led corporate computing functions
Manhattan Textile CorporationCFO; CEO (privately held export firm)Not disclosed Financial and executive leadership
Neuromedical Systems Inc.; Amplification Technologies, Inc.; Power Safe Technology Corp; Hinson Hale Medical Technologies Inc.Board Member (tech/medical start-ups)Not disclosed Early-stage governance experience

External Roles

OrganizationRoleTenureCommittee Roles
Acorn EnergyBoard Member15+ years Chair of Audit; Member of Nominating and Compensation
Several national non-profits (unnamed)Chairman of the BoardNot disclosed Governance in education-focused organizations

Board Governance

  • Committee assignments at KLTO:
    • Audit Committee: Chairperson (members: Zentman, Jon McGarity, Riad El-Dada); all independent and financially literate; Zentman qualifies as audit committee financial expert .
    • Compensation Committee: Member (chair: Jon McGarity; members: Zentman, Shalom Hirschman); all independent .
    • Nominating & Corporate Governance Committee: Member (chair: Shalom Hirschman; members: Zentman, Jon McGarity); all independent .
  • Independence: KLTO discloses committee independence under Nasdaq and SEC rules, with Zentman meeting independence and financial sophistication criteria .
  • Board attendance rate: Not disclosed in filings reviewed.
  • Lead Independent Director and executive session practices: Not disclosed.

Fixed Compensation

Component2024 AmountNotes
Annual cash retainer / Fees earned$0KLTO’s 10-K director compensation table shows “-” for Zentman in 2024 (only Hirschman received $120,000) .
Committee membership feesNot disclosedNo separate committee fee disclosure for 2024 .
Committee chair feesNot disclosedNo separate chair fee disclosure for 2024 .
Meeting feesNot disclosedNot detailed in filings .

Performance Compensation

Instrument / MetricGrant DateQuantityTerms (Strike/Expiration/Vesting)Performance Metrics
Incentive stock optionsNot disclosed30,000 (included in beneficial ownership) Not disclosed (strike, expiration, vesting not provided) None disclosed (no TSR/EBITDA/ESG metrics disclosed for director awards)

No PSUs/RSUs grants, vesting schedules, or performance metric links to director compensation were disclosed for Zentman in the filings reviewed .

Other Directorships & Interlocks

CompanyPublic/PrivateRolePotential Interlock/Conflict
Acorn EnergyPublic (status not specified in KLTO filing)Board Member; Audit Chair; Nominating & Compensation Member No KLTO filing indicates transactional ties; no related-party exposure disclosed under Item 404 .
Various tech/medical startups (listed above)PrivateDirectorNot disclosed; no related-party transactions flagged in KLTO Item 13 .

Expertise & Qualifications

  • Academic credentials: PhD in Complex Analysis; degrees from Wayne State and University of Michigan .
  • Technical expertise: Corporate computing and systems leadership at American Motors; audit committee financial expert designation .
  • Operating/finance: CFO and CEO experience (Manhattan Textile); extensive early-stage company governance .
  • Committee competence: Chairs KLTO’s Audit Committee; serves on Compensation and Nominating/Corporate Governance .

Equity Ownership

HolderShares Beneficially Owned% OutstandingComponents / Notes
Samuel Zentman612,9462.2%Includes 30,000 shares issuable upon exercise of incentive options . Denominator 28,011,351 shares as of March 26, 2025 .
Pledged sharesNot disclosedCompany states no arrangement, including any pledge, that may result in change in control, to its knowledge .
Ownership guidelines complianceNot disclosedNo director ownership guideline disclosed.

Governance Assessment

  • Strengths:
    • Independent director with audit committee financial expert status; chairs audit committee and participates in compensation and nom/gov committees—a strong indicator of governance depth .
    • Meaningful direct equity stake (2.2%) aligning interests; includes options exposure, though terms not disclosed .
  • Watch items:
    • Absence of disclosed cash fees in 2024 (unique relative to Hirschman’s fees) could reflect atypical cadence of director compensation; clarity on ongoing director pay structure would aid pay-for-performance evaluation .
    • Limited disclosure on director equity award terms (strike/expiration/vesting) and any performance conditions constrains assessment of incentive alignment .
  • Conflicts/related party exposure:
    • KLTO reports no Item 404 related-party transactions involving officers/directors; related party notes in 2023–2024 were to “members of management,” repaid by year-end 2024, with no director-specific linkage disclosed . The company also states, to its knowledge, no transactions requiring Item 404 disclosure .
  • Legal/red flags:
    • KLTO discloses no legal proceedings involving directors requiring Item 401(f) disclosure; no pledging identified that could impair alignment .

Overall signal: Zentman brings technical and finance depth and chairs Audit, with independence confirmed; ownership is aligned. Key disclosure gaps on director award terms and attendance remain, limiting a full pay-for-performance and engagement assessment .